Christopher Gottschalk, MD, is the chief of the Yale School of Medicine Division of General Neurology, as well as an assistant professor of neurology. Dr. Gottschalk established the first headache medicine program at Yale, the Yale Headache and Facial Pain Center, where he continues to treat patients with chronic headaches and facial pain. In addition to his clinical work at Yale, Dr. Gottschalk is researching ways to optimize interventions to improve headache diagnosis and management across medical specialties. Recurring moderate to severe headaches are often misdiagnosed and poorly treated, which is a problem that Dr. Gottschalk would like to change.
Archives: Experts
David Dodick, MD
David Dodick, M.D., FAAN, is a professor of neurology at the Mayo Clinic College of Medicine and Science in Scottsdale, Arizona. He is the director of the headache program and the sports neurology and concussion program at Mayo Clinic in Arizona. He is an adjunct professor in the department of neurosciences, Norwegian University of Science and Technology. Dr. Dodick is board certified by the Royal College of Physicians and Surgeons of Canada and the American Board of Psychiatry and Neurology (ABPN). He also holds United Council for Neurologic Subspecialties certification in headache medicine and ABPN certification in vascular neurology.
Dr. Dodick has authored more than 380 peer-reviewed publications and authored/edited 10 books. He is the chair of the American Migraine Foundation, chair of the American Academy of Neurology (AAN) Annual Program Concussion Committee, co-director of the American Registry of Migraine Research, chair of the International Registry for Migraine Research, chair of the International Headache Society Global Patient Advocacy Coalition, co-director of the Annual AAN Sports Concussion Conference, president-elect of the International Concussion Society, immediate past-president of the International Headache Society, former editor-in-chief of Cephalalgia, and past-president of the American Headache Society.
Eric Baron, DO
Dr. Eric P. Baron is a staff ABPN (American Board of Psychiatry and Neurology) Board Certified Neurologist and a UCNS (United Council for Neurologic Subspecialties) Diplomat Board Certified in Headache Medicine at Cleveland Clinic Neurological Institute, Center for Neurological Restoration – Headache and Chronic Pain Medicine, in Cleveland, Ohio.
He completed his Neurology Residency in 2009 at Cleveland Clinic, where he also served as Chief Neurology Resident. He then completed a Headache Medicine Fellowship in 2010, also at Cleveland Clinic, and has remained on as staff. He is also a Clinical Assistant Professor of Neurology at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
He has been repeatedly recognized as a “Top Doctor” as voted for by his peers in Cleveland Magazine, and has been repeatedly named one of “America’s Top Physicians”. He is an author of the popular neurology board review book, Comprehensive Review in Clinical Neurology: A Multiple Choice Question Book for the Wards and Boards, 1st and 2nd editions, and has authored many publications across a broad range of migraine and headache related topics.
To help patients and health care providers who do not have easy access to a headache specialist referral due to a shortage, he created and manages the Virtual Headache Specialist migraine, headache, and facial pain educational content, blog, and personalized headache and facial pain symptom checker tool at virtualheadachespecialist.com.
Interviews from Eric Baron, DO
The Latest on Medical Marijuana for Migraine
Medicinal Cannabis
Uwe Reuter, MD, PhD, MBA
Dr. Uwe Reuter is a professor of neurology at Charité University Hospital of Berlin, specializing in the role of CGRP in primary headaches. Dr. Reuter is a graduate of Johannes Gutenberg-Universität Mainz. He completed three years of postdoctoral studies at Harvard Medical School. At Harvard, Dr. Reuter focused on basic research in primary headaches and migraine aura. He continues his clinical practice and research in basic and clinical headaches. Dr. Reuter is a member of several national and international headache organizations, and currently serves as board member of the European Headache Federation.
Andrew Blumenfeld, MD
Dr. Andrew Blumenfeld is director of the Headache Center of Southern California. He graduated from the University of the Witwatersrand Medical School, and completed a neurology residency at Johannesburg Hospital. In 1986, he moved to the United States and completed a neurology residency, an EEG and EMG fellowship, all at the University of Massachusetts Medical School. He served as staff neurologist at Kaiser Permanente, San Diego from 1990 to 2004, and as chief of neurology Service at Kaiser, his unit was named a Neurotoxin Center of Excellence by Thomas Jefferson University and Jefferson Medical College.
Dr. Blumenfeld is board certified in neurology by the American Board of Psychiatry and Neurology. He is a member of the American Academy of Neurology and the American Headache Society. He has published widely and has been an active researcher in headache. Dr. Blumenfeld has been a principal investigator for many research studies, and regularly addresses national pharmaceutical meetings, medical conferences, continuing education seminars, and community events.
Interviews from Andrew Blumenfeld, MD
Botox: Separating Fact from Fiction
Treatment Spotlight: Nerve Blocks and Injections
Amaal J. Starling, MD, FAHS, FAAN
Dr. Amaal J. Starling is an associate professor of neurology at the Mayo Clinic College of Medicine. She joined the Mayo Clinic in 2012 and is currently a consultant within the Department of Neurology. Dr. Starling received her medical degree from the Drexel University College of Medicine in Philadelphia. She completed a transitional year residency, a neurology residency, and a headache fellowship at the Mayo Clinic College of Medicine in Scottsdale, Ariz.
Dr. Starling is an active member of numerous migraine advocacy organizations, including the American Headache Society (AHS), the American Migraine Foundation, and the American Academy of Neurology (AAN). She is also involved in events supporting migraine, including Headache on the Hill, Miles for Migraine, and the Alliance for Headache Disorders Advocacy. Dr. Starling is currently serving on the AHS Board of Directors and is the chair of the AHS Advocacy Committee and a member of the AHS Diversity, Equity, and Inclusion Taskforce. Dr. Starling has been the recipient of numerous awards, including the AHS Above and Beyond Award for Service, Manfred D. Muenter Award for Excellence in Clinical Neurology, the AAN Annual Meeting Residency Scholarship, the 2012 Spirit of Mayo Clinic Award, and the Mayo Brothers Distinguished Fellowship Award.
Dr. Starling has authored numerous peer-reviewed publications and abstracts related to her fields of interest, which include migraine, concussion, post-traumatic headache, neuromodulation, and telemedicine. Dr. Starling’s hope is that her research and advocacy will advance care for people with migraine, post-traumatic headache, and other headache disorders. She envisions a future in which all people with headache disorders receive personalized, effective, and well-tolerated treatment options to improve their quality of life.
Interviews from Amaal J. Starling, MD, FAHS, FAAN
SEEDS Natural Method for Migraine Control
Treatment Spotlight: Drug-Free Devices
When Nothing Works: Treatment-Resistant Chronic Migraine
How Can You Stand Up Against Migraine?
Pierangelo Geppetti, MD
Pierangelo Geppetti, MD, is a professor of clinical pharmacology at the Medical School of the University of Florence, and is the director of the Headache Center and Clinical Pharmacology Unit of the University Hospital of Careggi, Florence. Dr. Geppetti is an expert in the pharmacology of neuropeptides, particularly in the field of neurokinins and calcitonin gene-related peptide (neurogenic inflammation). He is a member of the Board of the Italian Association for the Study of Pain and of the Italian Society for the Study of Headaches.
His scientific activity has focused on primary sensory neurons and neurogenic mechanisms of inflammation in migraine and other types of pain. Dr. Geppetti has authored more than 200 articles in peer-reviewed journals and is co-author of a series of papers on the physiopharmacology of pain transmission and inflammation.
Mattias Linde, MD, PhD
Mattias Linde received his MD in 1993 at Lund University, Sweden, and in 2002 he became a specialist in neurology at Sahlgrenska University Hospital in Gothenburg, Sweden. In 2005, he received his doctorate with a thesis on migraine and worked as an associate professor of neurology. In 2010 he was recruited as a consultant at the National Advisory Unit for Headache in Norway (Trondheim). Since 2011 he has been a professor of neurology at the Department of Neuroscience, Norwegian University of Science and Technology (NTNU), Norway’s largest university. Currently, he supervises six doctoral students at NTNU.
Mattias Linde has written over 110 scientific articles, books, and textbook chapters mainly on the epidemiology and prophylaxis of migraine. He has collaborated with researchers in 18 countries and has worked in official relations with the World Health Organization (WHO). He is project manager for the first nationwide survey of headache disorders in Southeast Asia. He is a member of the editorial board of the Journal of Headache and Pain and of the board of the European Headache Federation (EHF).
Mark Braschinsky, MD
Dr. Mark Braschinsky graduated from the University of Tartu, faculty of medicine and neurology in Tartu, Estonia, in 2006. Immediately following, Dr. Braschinsky began work at the Tartu University Clinic at the University of Tartu, where he currently works as a senior physician in the field of neurology specializing in headaches. In 2010, Dr. Braschinsky created the SAU Head Pain Clinic, and soon after, he founded the Estonian Headache Society, of which he is president today. Dr. Braschinsky serves on the board of the European Headache Federation, the International Headache Society, and Central and Eastern Europe Against Migraine (Central and Eastern European Migraine). He is a member of a number of both national and international professional organizations, and he is the author of several publications in international peer-reviewed journals.
Interviews from Mark Braschinsky, MD
Angel Moreno, NP
As one of the top healthcare providers at UCLA’s Goldberg Migraine Program, Angel Moreno is a nurse practitioner who is currently earning his doctorate of nursing practice. His doctoral work focuses on the effects of a low-carbohydrate, ketogenic diet on pain. Angel Moreno is a certified yoga instructor and tonic herbalist. He applies aromatherapy, Chinese tonic herbalism and the principals of Chinese medicine to relieve pain. He’s here to help us sort through the pros and cons of different diets and make it simple to eat well.
Anna Andreou, PhD
Anna Andreou is the director of headache research at The Headache Centre, Guy’s and St. Thomas’ NHS Trust and Wolfson CARD, King’s College London. Dr. Andreou completed her PhD in neurology at the Institute of Neurology, Queen Square, where she investigated the therapeutic potentials of novel pharmacological innovations in migraine treatment. She then moved to the University of California, San Francisco, where she focused her research on the investigation of brain networks involved in headache pathophysiology and the effectiveness of neurostimulation in migraine. Dr. Andreou is now the senior Migraine Trust fellow based at the Wolfson CARD, King’s College London. Since the completion of her PhD, Dr. Andreou received a number of awards including the Thomas E. Heftler Migraine Research Award by the American Headache Society, the Early Research Career Grant by the International Association for the Study of Pain, and the Headache Research Excellence award from the International Headache Society. She is also a co-recipient of the Enrico Greppi Award in 2010, and she is a two-time recipient of the European Headache Migraine Trust International Congress New Scientist Lecture and the American Headache Society “Frontiers in Headache Research” Scholarship Award. Dr. Andreou served as the chair of the Trainees and Residents SIG of the International Headache Society for four years and she is now a chair of the IHS electronics media committee.
Interviews from Anna Andreou, PhD
Anne MacGregor, MD
Dr. Anne MacGregor is a world leader in studying the link between the menstrual cycle and migraine. She holds a doctorate in medicine from the University of London and a master’s in medical education from the Royal College of Physicians and University College London. Dr. MacGregor is an honorary professor at the Blizard Centre for Neuroscience, Surgery and Trauma; the Blizard Institute of Cell and Molecular Science; and Barts and The London School of Medicine and Dentistry. She has published more than 200 research papers, authored five books, co-authored an additional five books, and co-edited three books.
Dr. MacGregor has carried out extensive research into drug treatments for migraine and cluster headache, including significant research into menstrual migraine. Her doctoral thesis explored the role of estrogen in migraine, which led to the development of research criteria for menstrual migraine that were adopted by the International Headache Society in 2004. She has been awarded the Elizabeth Garrett Anderson Award for her extraordinary contribution to relieving those affected by the burden of headache and has received the Special Recognition Award and Honorary Life Membership from the International Headache Society. Dr. MacGregor regularly contributes to media discussions on the topic of migraine, particularly menstrual migraine.
